Alberta Separatist Referendum Could Reshape Canadas Energy Landscape South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Tensions RBIs 5 Billion FX Swap Oversubscribed Nearly Twofold Amid Rupee Defence Inherited Home Sale Strategy Navigating Capital Gains After Property Inheritance Reserve Bank of India Approves 287 Lakh Crore Dividend Transfer to Central Government for FY26 Allstate Corp Analyst Report Highlights Potential in Insurance Sector Edgewise Therapeutics Inc EWTX Q1 2026 Earnings Narrowerthanexpected loss underscores disciplined RD execution CMPS Q1 2026 Earnings Narrower Loss Drives Positive Investor Sentiment QUAD Q1 2026 Earnings EPS Beats Estimates by 14 Stock Climbs Marginally FPI Q1 2026 Earnings Earnings Per Share Misses Estimates Amid Seasonal Farmland Dynamics HRL Q1 2026 Earnings Earnings Per Share Surpass Analyst Estimates ALXO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Evorpacept Development Smith Nephew SNN Faces Pressure Stock Slips 141 Amid Cautious Market Sentiment Pinnacle Financial Partners PNFP Edges Lower Amid Modest Pullback Key Support Levels in Focus Interparfums IPAR Rallies 263 as Fragrance Sector Momentum Builds Sotherly Hotels Preferred Stock SOHON Holds Steady Near Support as Yield Attracts Investors Illumina ILMN Surges Over 4 as Positive Momentum Builds Toward Key Resistance The Hidden Cost of Financial Concealment When Couples Fake Financial Struggles to Fit In Gujarat Government Partners with Meta to Deliver Certificates via WhatsApp Boosting Digital Governance JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India MD Discusses Business Outlook Trumps Stock Trade Disclosures Spark Scrutiny Over Potential Conflicts of Interest Amazon Taps Amwell CoFounder as New Health Chief Amid Executive Departure Shein Acquires Everlane Can the Fast Fashion Giant Reshape Ethical Luxury China Industrial Profits Surge 247 in April Fastest Growth Since November 2023 ULBI Q1 2026 Earnings Earnings Miss but Stock Gains Signaling Investor Optimism CytoMed Therapeutics GDTC Drops 738 Key Support Levels in Focus Amid Selling Pressure